Literature DB >> 17633873

[Upper gastrointestinal bleeding as a surgical complication of primary gastric lymphoma].

D Velicković1, P Sabljak, K Ebrahimi, M Bjelović, D Stojakov, B Nenadić, B Spica, V Sljukic, P Pesko.   

Abstract

Primary gastric lymphomas are of the extranodal non-Hodgkin type. The gastrointestinal tract is the most common site of extranodal non-Hodgkin lymphomas and accounts 30-45% of all extranodal lymphomas. Gastrointestinal lymphomas occurs in the stomach in 55-70% of cases. Primary gastric lymphoma is relatively rare tumor accounting 1-7%, of all gastric malignancies. An increased incidence has been documented recently. The median age of diagnosis is approximately 60 years old, and disease affects an equal number of men and women. The initial symptoms may be vague and nonspecific leading to delayed establishment of diagnosis up to several years. Many patients came down late with advanced disease and complications such as upper gastrointestinal bleeding. Twenty to thirty percent may present with occult bleeding or hematemesis et melena while gastric obstruction and perforation are less common. Gastric bleeding can also occur as a complication of chemotherapy. The incidence of gastric bleeding in patients receiving chemotherapy is up to 11%. In most cases surgical resection is necessary to achieve hemostasis. Given the rate of surgical complications, especially gastric bleeding, there is still an important role for surgeon in the multimodal treatment of patients with primary gastric lymphoma.

Entities:  

Mesh:

Year:  2007        PMID: 17633873     DOI: 10.2298/aci0701131v

Source DB:  PubMed          Journal:  Acta Chir Iugosl        ISSN: 0354-950X


  2 in total

1.  Primary gastrointestinal mantle lymphoma with massive bleeding: a case report and literature review.

Authors:  Wen Zheng; Yuqin Song; Ningjing Lin; Meifeng Tu; Weiping Liu; Jun Zhu
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

2.  Clinical analysis of Primary Gastrointestinal Non-Hodgkin's Lymphoma.

Authors:  Wei Wang; Peng Lin; Haiying Yao; Xi Jia; Jirui Sun
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.